Related Experiment Videos
An improved method to quantitate phagocytosis with mineral oil particles which avoid cell flotation
Journal of Immunological Methods
|January 22, 1986
Summary
Researchers developed a new method to accurately measure phagocytosis by human polymorphonuclear leukocytes (PMN). This improved assay overcomes limitations of previous techniques, enabling a more precise quantification of phagocytic activity.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Phagocytosis is a critical cellular process mediated by immune cells like polymorphonuclear leukocytes (PMN).
- Accurate quantitation of phagocytosis is essential for understanding immune function and disease.
- Previous methods using Oil Red O-stained paraffin oil particles underestimated phagocytosis due to cell flotation.
Purpose of the Study:
- To develop a reliable method for quantifying phagocytosis by human PMN.
- To overcome the underestimation issue caused by cell flotation in existing assays.
- To establish a new assay for measuring both the rate and capacity of phagocytosis.
Main Methods:
- Prepared paraffin oil-silicon oil particles with densities ranging from 0.8740 to 0.9952 g/cm³.
- Utilized particles with sufficient density to prevent PMN flotation during phagocytosis assays.
- Quantitated phagocytosis using Oil Red O dye and measured uptake by PMN.
Main Results:
- A density of 0.9952 g/cm³ for paraffin oil-silicon oil particles was found to prevent PMN flotation.
- The new assay revealed an initial phagocytosis rate of 400 µg/min/5x10⁶ PMN, approximately 20 times higher than previously reported.
- Maximum phagocytic capacity was determined to be 2.5 mg/5x10⁶ PMN, and particle uptake was sensitive to known phagocytosis inhibitors.
Conclusions:
- A novel, accurate assay for quantifying human PMN phagocytosis has been established using density-adjusted oil particles.
- This method provides significantly higher measurements of phagocytic rate and capacity compared to older techniques.
- The assay is sensitive to inhibitors and can detect alterations in phagocytosis, such as in myeloperoxidase-deficient PMN.